Guilherme Jorge Costa

Guilherme Jorge Costa

Auto-generated profile, based on publicly available information

Guilherme Jorge Costa

Instituto de Medicina Integral Professor Fernando Figueira—IMIP Pernambuco Brazil

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in Jornal Brasileiro de Pneumologia
Verified
Journal Article
Open access
PDF file
GCGuilherme Jorge Costa
Guilherme Jorge Costa
MMMaria Júlia Gonçalves DE MELLO
Maria Júlia Gonçalves DE MELLO
ABAnke Katharina Bergmann
Anke Katharina Bergmann
CFCarlos Gil Ferreira
Carlos Gil Ferreira
LTLuiz Claudio Santos Thuler
Luiz Claudio Santos Thuler
Objective: To characterize the clinical and histological profile, as well as treatment patterns, of patients with early-stage, locally advanced (LA), or advanced/metastatic (AM) lung cancer, diagnosed between 2000 and 2014, in Brazil. Methods: This was an analytical cross-sectional epidemiological study employing data obtained for the 2000-2014 period from the hospital cancer registries of two institutions in Brazil: the José Alencar Gomes da Silva National Cancer Institute, in the city of Rio de Janeiro; and the São Paulo Cancer Center Foundation, in the city of São Paulo. Results: We reviewed the data related to 73,167 patients with lung cancer. The proportions of patients with early-stage, LA, and AM lung cancer were 13.3%, 33.2%, and 53.4%, respectively. The patients with early-stage lung cancer were older and were most likely to receive a histological diagnosis of adenocarcinoma; the proportion of patients with early-stage lung cancer remained stable throughout the study period. In those with LA lung cancer, squamous cell carcinoma predominated, and the proportion of patients with LA lung cancer decreased significantly over the period analyzed. Those with AM lung cancer were younger and were most likely to have adenocarcinoma; the proportion of patients with AM lung cancer increased significantly during the study period. Small cell carcinoma accounted for 9.2% of all cases. In our patient sample, the main treatment modality was chemotherapy. Conclusions: It is noteworthy that the frequency of AM lung cancer increased significantly during the study period, whereas that of LA lung cancer decreased significantly and that of early-stage lung cancer remained stable. Cancer treatment patterns, by stage, were in accordance with international guidelines.

1 November 2018 in Lung Cancer
Verified
Journal Article
Closed access
GCGuilherme Jorge Costa
Guilherme Jorge Costa
MMMaria Júlia Gonçalves de Mello
Maria Júlia Gonçalves de Mello
CFCarlos Gil Ferreira
Carlos Gil Ferreira
ABAnke Bergmann
Anke Bergmann
LTLuiz Claudio Santos Thuler
Luiz Claudio Santos Thuler

3 August 2021 in Cancer
Verified
Journal Article
Open access
PDF file
GCGuilherme Jorge Costa
Guilherme Jorge Costa
CACarla Rameri Alexandre Silva de Azevedo
Carla Rameri Alexandre Silva de Azevedo
JJJosé Iran Costa Júnior
José Iran Costa Júnior
ABAnke Katharina Bergmann
Anke Katharina Bergmann
LTLuiz Claudio Santos Thuler
Luiz Claudio Santos Thuler
Background: Coronavirus disease 2019 (COVID‐19) and cancer are serious public health problems worldwide. However, little is known about the risk factors of in‐hospital mortality among COVID‐19 patients with and without cancer in Brazil. The objective of this study was to evaluate the risk factors of in‐hospital mortality among COVID‐19 patients with and without cancer and to compare mortality according to gender and topography during the year 2020 in Brazil.Methods: This was a secondary data study of hospitalized adult patients with a diagnosis of COVID‐19 by real‐time polymerase chain reaction testing in Brazil. The data were collected from the Influenza Epidemiological Surveillance Information System.Results: This study analyzed data from 322,817 patients. The prevalence of cancer in patients with COVID‐19 was 2.3%. COVID‐19 patients with neurological diseases and cancer had the most lethal comorbidities in both sexes. COVID‐19 patients with cancer were more likely to be older (median age, 67 vs 62 years; P < .001), to have a longer hospital stay (13.1 vs 11.5 days; P < .001), to be admitted to the intensive care unit (45.3% vs 39.6%; P < .001), to receive more invasive mechanical ventilation (27.1% vs 21.9%), and to have a higher risk of death (adjusted odds ratio [aOR], 1.94; 95% confidence interval [CI], 1.83‐2.06; P < .001) than those without cancer. Patients with hematological neoplasia (aOR, 2.85; 95% CI, 2.41‐3.38; P < .001) had a higher risk of mortality than those with solid tumors (aOR, 1.83; 95% CI, 1.72‐1.95; P < .001) in both sexes.Conclusions: Brazilian COVID‐19 patients with cancer have higher disease severity and a higher risk of mortality than those without cancer.

1 May 2021 in Clinical Lung Cancer
Verified
Journal Article
Closed access
GCGuilherme Jorge Costa
Guilherme Jorge Costa
GSGustavo Telles da Silva
Gustavo Telles da Silva
CFCarlos Gil Ferreira
Carlos Gil Ferreira
MMMaria Júlia Gonçalves de Mello
Maria Júlia Gonçalves de Mello
ABAnke Bergmann
Anke Bergmann
LTLuiz Cláudio Santos Thuler
Luiz Cláudio Santos Thuler

16 June 2023 in Cancer Epidemiology
Verified
Journal Article
Closed access
AFAna Luiza Fassizoli da Fonte
Ana Luiza Fassizoli da Fonte
GCGuilherme Jorge Costa
Guilherme Jorge Costa
ANAdilis Stepple da Fonte Neto
Adilis Stepple da Fonte Neto
RPRodrigo Alves Pinto
Rodrigo Alves Pinto
MMMaria Júlia Gonçalves de Mello
Maria Júlia Gonçalves de Mello

29 January 2021 in Future Oncology
Verified
Journal Article
Closed access
LSLarissy Machado da Silva
Larissy Machado da Silva
GSGustavo Telles da Silva
Gustavo Telles da Silva
ABAnke Katharina Bergmann
Anke Katharina Bergmann
GCGuilherme Jorge Costa
Guilherme Jorge Costa
MZMauro Musa Zamboni
Mauro Musa Zamboni
LTLuiz Claudio Santos Thuler
Luiz Claudio Santos Thuler
Aim: The aim of this study was to evaluate the frequency and median time for the development of metastases and prognosis by metastatic site after the diagnosis of non-small-cell lung cancer (NSCLC)... Lay abstract In this study, we evaluated patients with lung cancer, focusing mainly on the development of metastases and how they affect patient survival. To this end, we conducted a study of 1096 ...